Kerkmeijer, L. G., Fuller, C. D., Verkooijen, H. M., et al. (2016). The MRI-linear accelerator consortium: Evidence-based clinical introduction of an innovation in radiation oncology connecting researchers, methodology, data collection, quality assurance, and technical development. Frontiers in Oncology, 6, 215. https://doi.org/10.3389/fonc.2016.00215.
Article
PubMed
PubMed Central
Google Scholar
Lagendijk, J. J., Raaymakers, B. W., Raaijmakers, A. J., et al. (2008). MRI/linac integration. Radiotherapy and oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 86, 25–29. https://doi.org/10.1016/j.radonc.2007.10.034.
Article
Google Scholar
Pathmanathan, A. U., van As, N. J., Kerkmeijer, L. G. W., et al. (2018). Magnetic resonance imaging-guided adaptive radiation therapy: A "game changer" for prostate treatment? International Journal of Radiation Oncology, Biology, Physics, 100, 361–373. https://doi.org/10.1016/j.ijrobp.2017.10.020.
Article
PubMed
Google Scholar
Bertelsen, A. S., Schytte, T., Møller, P. K., Mahmood, F., Riis, H. L., Gottlieb, K. L., … Bernchou, U. (2019). First clinical experiences with a high field 1.5 T MR linac. Acta oncologica (Stockholm, Sweden), 58(10), 1352–1357. https://doi.org/10.1080/0284186x.2019.1627417.
Article
Google Scholar
Dueck, A. C., Becker, C. C., Rogak, L. J., et al. (2020). Composite grading algorithm for National Cancer Institute’s PRO-CTCAE. Journal of Clinical Oncology, 38, 7018–7018. https://doi.org/10.1200/JCO.2020.38.15_suppl.7018.
Article
Google Scholar
Cree, A., Livsey, J., Barraclough, L., et al. (2018). The potential value of MRI in external-beam radiotherapy for cervical cancer. Clinical Oncology (Royal College of Radiologists), 30, 737–750. https://doi.org/10.1016/j.clon.2018.08.002.
Article
CAS
Google Scholar
Andreyev, J. (2007). Gastrointestinal symptoms after pelvic radiotherapy: A new understanding to improve management of symptomatic patients. The Lancet Oncology, 8, 1007–1017. https://doi.org/10.1016/s1470-2045(07)70341-8.
Article
PubMed
Google Scholar
Nicholas, S., Chen, L., Choflet, A., et al. (2017). Pelvic radiation and Normal tissue toxicity. Seminars in Radiation Oncology, 27, 358–369. https://doi.org/10.1016/j.semradonc.2017.04.010.
Article
PubMed
Google Scholar
Stone, H. B., Coleman, C. N., Anscher, M. S., & McBride, W. H. (2003). Effects of radiation on normal tissue: Consequences and mechanisms. The Lancet Oncology, 4(9), 529–536. https://doi.org/10.1016/S1470-2045(03)01191-4.
Article
CAS
PubMed
Google Scholar
White, K. L., Varrassi, E., Routledge, J. A., et al. (2018). Does the use of volumetric modulated arc therapy reduce gastrointestinal symptoms after pelvic radiotherapy? Clinical Oncology (Royal College of Radiologists), 30, e22–e28. https://doi.org/10.1016/j.clon.2017.10.016.
Article
CAS
Google Scholar
Trotti, A., Colevas, A. D., Setser, A., et al. (2007). Patient-reported outcomes and the evolution of adverse event reporting in oncology. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 25, 5121–5127. https://doi.org/10.1200/jco.2007.12.4784.
Article
Google Scholar
Aapro, M., Bossi, P., Dasari, A., et al. (2020). Digital health for optimal supportive care in oncology: Benefits, limits, and future perspectives. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 28, 4589–4612. https://doi.org/10.1007/s00520-020-05539-1.
Article
CAS
Google Scholar
Verkooijen, H. M., Kerkmeijer, L. G. W., Fuller, C. D., Huddart, R., Faivre-Finn, C., Verheij, M., … Schultz, C. (2017). R-IDEAL: A framework for systematic clinical evaluation of technical innovations in radiation oncology. Frontiers in Oncology, 7, 59. https://doi.org/10.3389/fonc.2017.00059.
Article
PubMed
PubMed Central
Google Scholar
Di Maio, M., Gallo, C., Leighl, N. B., et al. (2015). Symptomatic toxicities experienced during anticancer treatment: Agreement between patient and physician reporting in three randomized trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 33, 910–915. https://doi.org/10.1200/jco.2014.57.9334.
Article
Google Scholar
Falchook, A. D., Green, R., Knowles, M. E., et al. (2016). Comparison of patient- and practitioner-reported toxic effects associated with Chemoradiotherapy for head and neck cancer. JAMA Otolaryngology. Head & Neck Surgery, 142, 517–523. https://doi.org/10.1001/jamaoto.2016.0656.
Article
Google Scholar
Basch, E., Iasonos, A., McDonough, T., et al. (2006). Patient versus clinician symptom reporting using the National Cancer Institute common terminology criteria for adverse events: Results of a questionnaire-based study. The Lancet Oncology, 7, 903–909. https://doi.org/10.1016/s1470-2045(06)70910-x.
Article
PubMed
Google Scholar
Gilbert, A., Ziegler, L., Martland, M., et al. (2015). Systematic review of radiation therapy toxicity reporting in randomized controlled trials of rectal cancer: A comparison of patient-reported outcomes and clinician toxicity reporting. International Journal of Radiation Oncology, Biology, Physics, 92, 555–567. https://doi.org/10.1016/j.ijrobp.2015.02.021.
Article
PubMed
Google Scholar
Tom, A., Bennett, A. V., Rothenstein, D., et al. (2018). Prevalence of patient-reported gastrointestinal symptoms and agreement with clinician toxicity assessments in radiation therapy for anal cancer. Quality of Life Research: an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 27, 97–103. https://doi.org/10.1007/s11136-017-1700-8.
Article
Google Scholar
Fokdal, L., Potter, R., Kirchheiner, K., et al. (2018). Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer. Radiotherapy and oncology : Journal of the European Society for Therapeutic Radiology and Oncology. https://doi.org/10.1016/j.radonc.2018.05.002.
Hoffman, K. E., Penson, D. F., Zhao, Z., et al. (2020). Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer. Jama, 323, 149–163. https://doi.org/10.1001/jama.2019.20675.
Article
PubMed
PubMed Central
Google Scholar
Petrella, T. M., Robert, C., Richtig, E., Miller Jr., W. H., Masucci, G. V., Walpole, E., … Cebon, J. (2017). Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma. European Journal of Cancer, 86, 115–124. https://doi.org/10.1016/j.ejca.2017.08.032.
Article
CAS
PubMed
Google Scholar
Bruynzeel, A. M. E., Tetar, S. U., Oei, S. S., et al. (2019). A prospective single-arm phase 2 study of stereotactic magnetic resonance guided adaptive radiation therapy for prostate cancer: Early toxicity results. International Journal of Radiation Oncology, Biology, Physics, 105, 1086–1094. https://doi.org/10.1016/j.ijrobp.2019.08.007.
Article
CAS
PubMed
Google Scholar
Tetar, S. U., Bruynzeel, A. M. E., Oei, S. S., et al. (2020). Magnetic resonance-guided stereotactic radiotherapy for localized prostate cancer: Final results on patient-reported outcomes of a prospective phase 2 study. European rology oncology. https://doi.org/10.1016/j.euo.2020.05.007.
Alongi, F., Rigo, M., Figlia, V., et al. (2020). 1.5 T MR-guided and daily adapted SBRT for prostate cancer: Feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment. Radiation ncology (London, England), 15, 69. https://doi.org/10.1186/s13014-020-01510-w.
Article
CAS
Google Scholar
Mazzola, R., Figlia, V., Rigo, M., et al. (2020). Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: Geriatric assessment tools and preliminary patient-reported outcomes. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-020-03230-w.
Pappot, H., & Taarnhøj, G. A. (2020). Expectations to patient-reported outcome (PRO) in oncology - PRO for a purpose, when and how? Acta oncologica (Stockholm, Sweden), 59, 611–612. https://doi.org/10.1080/0284186x.2020.1749880.
Article
Google Scholar
Nissen, A., Bager, L., & Pappot, H. (2019). The use of PRO in adverse event identification during cancer therapy - choosing the right questions to ask. Acta oncologica (Stockholm, Sweden), 58, 596–602. https://doi.org/10.1080/0284186x.2018.1560496.
Article
Google Scholar
Pappot, H., & Taarnhøj, G. A. (2020). Expectations to Patient-Reported Outcome (PRO) in oncology-PRO for a purpose, when and how? Acta oncologica, 1–2. https://doi.org/10.1080/0284186X.2020.1749880.
Ramsey, I., Eckert, M., Hutchinson, A. D., et al. (2020). Core outcome sets in cancer and their approaches to identifying and selecting patient-reported outcome measures: A systematic review. Journal of Patient-reported Outcomes, 4, 77. https://doi.org/10.1186/s41687-020-00244-3.
Article
PubMed
PubMed Central
Google Scholar
Sandler, K. A., Mitchell, S. A., Basch, E., et al. (2018). Content validity of anatomic site-specific patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) item sets for assessment of acute symptomatic toxicities in radiation oncology. International Journal of Radiation Oncology, Biology, Physics, 102, 44–52. https://doi.org/10.1016/j.ijrobp.2018.04.048.
Article
PubMed
Google Scholar
Winkel, D., Kroon, P. S., Werensteijn-Honingh, A. M., et al. (2018). Simulated dosimetric impact of online replanning for stereotactic body radiation therapy of lymph node oligometastases on the 1.5T MR-linac. Acta oncologica (Stockholm, Sweden), 57, 1705–1712. https://doi.org/10.1080/0284186x.2018.1512152.
Article
CAS
Google Scholar
Nachbar, M., Mönnich, D., Kalwa, P., et al. (2019). Comparison of treatment plans for a high-field MRI-linac and a conventional linac for esophageal cancer. Strahlentherapie und Onkologie, 195, 327–334. https://doi.org/10.1007/s00066-018-1386-z.
Article
PubMed
Google Scholar
Bainbridge, H. E., Menten, M. J., Fast, M. F., Nill, S., Oelfke, U., & McDonald, F. (2017). Treating locally advanced lung cancer with a 1.5T MR-Linac - effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 125(2), 280–285. https://doi.org/10.1016/j.radonc.2017.09.009.
Article
Google Scholar
Taarnhøj, G. A., Lindberg, H., Johansen, C., & Pappot, H. (2019). Patient-reported outcomes item selection for bladder cancer patients in chemo-or immunotherapy. Journal of Patient-reported Outcomes, 3(1), 56. https://doi.org/10.1186/s41687-019-0141-2.
Article
PubMed
PubMed Central
Google Scholar
Tolstrup, L. K., Bastholt, L., Zwisler, A.-D., Dieperink, K. B., & Pappot, H. (2019). Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy. Journal of Patient-reported Outcomes, 3(1), 19. https://doi.org/10.1186/s41687-019-0111-8.
Article
PubMed
PubMed Central
Google Scholar
Holch, P., Warrington, L., Potrata, B., et al. (2016). Asking the right questions to get the right answers: Using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients. Acta Oncologica (Stockholm, Sweden), 55, 1220–1226. https://doi.org/10.1080/0284186x.2016.1213878.
Article
Google Scholar
Chiang-Hanisko, L., Newman, D., Dyess, S., et al. (2016). Guidance for using mixed methods design in nursing practice research. Applied Nursing Research, 31, 1–5. https://doi.org/10.1016/j.apnr.2015.12.006.
Article
PubMed
Google Scholar
Veritas Health Innovation, M, Australia. Covidence systematic review software. In. www.covidence.org. Accessed 2 July 2019.
Moher, D., Liberati, A., Tetzlaff, J., et al. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Journal of Clinical Epidemiology, 62, 1006–1012. https://doi.org/10.1016/j.jclinepi.2009.06.005.
Article
PubMed
Google Scholar
Basch, E., Reeve, B. B., Mitchell, S. A., et al. (2014). Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Journal of the National Cancer Institute, 106. https://doi.org/10.1093/jnci/dju244.
Kulis, D., Bottomley, A., Whittaker, C., et al. (2017). The use of the Eortc item library to supplement Eortc quality of life instruments. Value in Health, 20, A775. https://doi.org/10.1016/j.jval.2017.08.2236.
Article
Google Scholar
Dueck, A. C., Mendoza, T. R., Mitchell, S. A., et al. (2015). Validity and reliability of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). JAMA Oncology, 1, 1051–1059. https://doi.org/10.1001/jamaoncol.2015.2639.
Article
PubMed
PubMed Central
Google Scholar
Baeksted, C., Pappot, H., Nissen, A., et al. (2016). Feasibility of an electronic patient-reported outcome intervention based on the patient-reported outcomes version of common terminology criteria for adverse events ( PRO-CTCAE) in Danish prostate cancer patients. Quality of Life Research, 25, 40–40.
Google Scholar
Mendoza, T. R., Dueck, A. C., Bennett, A. V., Mitchell, S. A., Reeve, B. B., Atkinson, T. M., … Basch, E. (2017). Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE. Clinical Trials (London, England), 14(3), 255–263. https://doi.org/10.1177/1740774517698645.
Article
Google Scholar
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982). Toxicity and response criteria of the eastern cooperative oncology group. American Journal of Clinical Oncology, 5(6), 649–655. https://doi.org/10.1097/00000421-198212000-00014.
Article
CAS
PubMed
Google Scholar
CIMT (2021). My hospital (Centre for Innovative Medical Technology). https://cimt.dk/gb/mit-sygehus/.
Google Scholar
Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are enough?: An experiment with data saturation and variability. Field Methods, 18(1), 59–82. https://doi.org/10.1177/1525822x05279903.
Article
Google Scholar
Malterud, K. (2012). Systematic text condensation: A strategy for qualitative analysis. Scandinavian Journal of Public Health, 40(8), 795–805.10.1177/1403494812465030. https://doi.org/10.1177/1403494812465030.
Article
PubMed
Google Scholar
Chiloiro, G., Boldrini, L., Meldolesi, E., et al. (2019). MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology. Clinical Translational of Radiation Oncology, 18, 80–86. https://doi.org/10.1016/j.ctro.2019.04.006.
Article
Google Scholar
Institute, NNC (2019). Common terminology criteria for adverse events (CTCAE).
Google Scholar
Taarnhøj, G. A., Kennedy, F. R., Absolom, K. L., Bæksted, C., Vogelius, I. R., Johansen, C., … Pappot, H. (2018). Comparison of EORTC QLQ-C30 and PRO-CTCAE™ questionnaires on six symptom items. Journal of Pain and Symptom Management, 56(3), 421–429. https://doi.org/10.1016/j.jpainsymman.2018.05.017.
Article
PubMed
Google Scholar
Atkinson, T. M., Ryan, S. J., Bennett, A. V., et al. (2016). The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): A systematic review. Support Care Cancer, 24, 3669–3676. https://doi.org/10.1007/s00520-016-3297-9.
Article
PubMed
PubMed Central
Google Scholar
Halkett, G. K. B., Wigley, C. A., Aoun, S. M., et al. (2018). International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: A phase IV study. Radiation ncology (London, England), 13, 162. https://doi.org/10.1186/s13014-018-1107-x.
Article
Google Scholar
Kotronoulas, G., Kearney, N., Maguire, R., et al. (2014). What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 32, 1480–1501. https://doi.org/10.1200/jco.2013.53.5948.
Article
Google Scholar
Bottomley, A., Reijneveld, J. C., Koller, M., et al. (2019). Current state of quality of life and patient-reported outcomes research. European Journal of Cancer, 121, 55–63. https://doi.org/10.1016/j.ejca.2019.08.016.
Article
PubMed
Google Scholar